SCHEMBL8716883

SCHEMBL8716883

CC(=O)Nc1ccc(C)c(NC(C)=O)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.65
ALDH1A1 P00352 7/20 0.57
HPGD P15428 1/20 0.57
TDP1 Q9NUW8 1/20 0.55
HSD17B10 Q99714 1/20 0.53
MAPT P10636 5/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
LMNA P02545 3/20 0.53
HTT P42858 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
MEN1 O00255 4/20 0.50
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA9 Q16790 2/20 0.50
KDM4E B2RXH2 1/20 0.50
GLA P06280 1/20 0.50
TNNI3 P19429 1/20 0.50
TNNT2 P45379 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31725340 1.00 KMT2A (0.65) KMT2AALDH1A1HPGDTDP1HSD17B10
SCHEMBL16329825 0.93 KMT2A (0.58) KMT2AALDH1A1HPGDTDP1HSD17B10
SCHEMBL12937737 0.92 KMT2A (0.57) KMT2AALDH1A1HPGDTDP1HSD17B10
SCHEMBL21310281 0.89 KMT2A (0.58) KMT2AALDH1A1HPGDTDP1HSD17B10
SCHEMBL18814671 0.88 KMT2A (0.57) KMT2AALDH1A1HPGDTDP1HSD17B10
SCHEMBL13202313 0.88 SMN1; SMN2 (0.62) KMT2AALDH1A1HPGDTDP1HSD17B10
SCHEMBL13104616 0.88 SMN1; SMN2 (0.62) KMT2AALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL11026473 0.87 KMT2A (0.56) KMT2AALDH1A1HPGDTDP1HSD17B10
SCHEMBL3239869 0.85 L3MBTL1 (0.62) KMT2AALDH1A1TDP1MAPTSMN1; SMN2
SCHEMBL13963786 0.85 KMT2A (0.58) KMT2AALDH1A1TDP1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12034115-B2 Solid electrolyte composition, sheet for all-solid state secondary battery, electrode sheet for all-solid state secondary battery, and all-solid state secondary battery FUJIFILM CORPORATION (JP) 2024-07-09 US disclosed
US-9879108-B2 Composition, cured film, color filter, laminate, and pigment dispersant FUJIFILM CORPORATION (JP) 2018-01-30 US disclosed
US-9605101-B2 Pigment multimer, coloring composition, cured film, color filter, method for manufacturing color filter, solid-state imaging element, and image display device FUJIFILM CORPORATION (JP) 2017-03-28 US disclosed
US-9605101-B2 Pigment multimer, coloring composition, cured film, color filter, method for manufacturing color filter, solid-state imaging element, and image display device FUJIFILM CORPORATION (JP) 2017-03-28 US disclosed
US-9593197-B2 Trigger-responsive chain-shattering polymers THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-03-14 US disclosed
US-9519079-B2 Coloring composition, colored pattern, color filter and method of producing the same, pattern forming method, solid-state imaging device, and image display device FUJIFILM CORPORATION (JP) 2016-12-13 US disclosed
US-9470974-B2 Coloring composition, coloring radiation-sensitive composition, color filter and solid-state imaging device FUJIFILM CORPORATION (JP) 2016-10-18 US disclosed
US-9442231-B2 Colored composition, cured film, color filter, method for producing color filter, solid-state image sensor, and image display device FUJIFILM CORPORATION (JP) 2016-09-13 US disclosed
US-20160146986-A1 COLORED COMPOSITION, CURED FILM, COLOR FILTER, METHOD FOR PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2016-05-26 US disclosed
US-20160108161-A1 PIGMENT MULTIMER, COLORING COMPOSITION, CURED FILM, COLOR FILTER, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING ELEMENT, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2016-04-21 US disclosed
US-20100055613-A1 NEGATIVE-WORKING LITHOGRAPHIC PRINTING PLATE PRECURSOR AND METHOD OF LITHOGRAPHIC PRINTING USING SAME FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed
US-20080199804-A1 Including free radical binder polymer containing functional group having dipole moment of 3.8 debye; laser computer controlled direct plate making without alkali development; sensitivity, printing durability FUJIFILM CORPORATION (JP) 2008-08-21 US disclosed
US-20080070154-A1 DECOMPOSABLE RESIN COMPOSITION AND PATTERN-FORMING MATERIAL INCLUDING THE SAME FUJIFILM CORPORATION (JP) 2008-03-20 US disclosed
US-5739350-A COMPOUNDS CAPABLE OF BEING LINKED TO MONOCLONAL ANTIBODIES FOR DELIVERY TO TARGET CELLS PHARMACIA & UPJOHN COMPANY (US) 1998-04-14 US disclosed
US-4600797-A NITRATING AN AMINOBENZENE WHICH HAS A PROTECTEDD AMINO GROUP BAYER AKTIENGESELLSCHAFT (DE) 1986-07-15 US disclosed
EP-0049711-B1 PROCESS FOR THE PRODUCTION OF NITRO-AMINO-BENZENES BAYER AG (DE) 1984-02-29 EP disclosed
EP-0049711-A1 Process for the production of nitro-amino-benzenes BAYER AG (DE) 1982-04-21 EP disclosed
US-4264619-A Tertiary aminoacids CIBA-GEIGY CORPORATION (US) 1981-04-28 US disclosed
US-4163788-A ANTIINFLAMMATORY CIBA-GEIGY CORPORATION (US) 1979-08-07 US disclosed
US-4100351-A Method for preparing aromatic urethans ANIC, S.P.A. (IT) 1978-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160108161-A1 PIGMENT MULTIMER, COLORING COMPOSITION, CURED FILM, COLOR FILTER, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING ELEMENT, AND IMAGE DISPLAY DEVICE CUTA, SLC5A6, SETDB1 KMT2A 143/4885ALDH1A1 1641/4885HPGD 4120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.